An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia. (Q51741053)
Jump to navigation
Jump to search
scientific article published on 31 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia. |
scientific article published on 31 October 2016 |
Statements
1 reference
An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia. (English)
1 reference
Masato Murakami
1 reference
Kenichi Osada
1 reference
Hisao Ichibayashi
1 reference
Hiromichi Mizuno
1 reference
Toshimitsu Ochiai
1 reference
Mitsuhiro Ishida
1 reference
Levent Alev
1 reference
Kusuki Nishioka
1 reference
31 October 2016
1 reference
1 reference
27
1 reference
688-695
1 reference
4
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference